Format
Sort by
Items per page

Send to

Choose Destination

Best matches for testosterone therapy for women:

Testosterone therapy for menopausal women. et al. Drug Ther Bull. (2017)

Testosterone in Women: Measurement and Therapeutic Use. Kathryn Korkidakis A et al. J Obstet Gynaecol Can. (2017)

Testosterone Therapies. Khera M et al. Urol Clin North Am. (2016)

Search results

Items: 1 to 20 of 4202

1.

Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals.

Fuss J, Claro L, Ising M, Biedermann SV, Wiedemann K, Stalla GK, Briken P, Auer MK.

Psychoneuroendocrinology. 2019 Mar 14;104:228-237. doi: 10.1016/j.psyneuen.2019.02.023. [Epub ahead of print]

PMID:
30897530
2.

Fertility preservation options for transgender and gender-nonconforming individuals.

Moravek MB.

Curr Opin Obstet Gynecol. 2019 Feb 18. doi: 10.1097/GCO.0000000000000537. [Epub ahead of print]

PMID:
30870185
3.

Kallmann Syndrome.

Sonne J, Lopez-Ojeda W.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Feb 20.

4.

Exogenous Testosterone Does Not Influence 11-Oxygenated C19 Steroid Concentrations in Healthy Postmenopausal Women.

Davis SR, Turcu AF, Robinson PJ, Bell RJ.

J Endocr Soc. 2019 Feb 4;3(3):670-677. doi: 10.1210/js.2018-00412. eCollection 2019 Mar 1.

5.

No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender Incongruence.

Defreyne J, Kreukels B, T'Sjoen G, Staphorsius A, Den Heijer M, Heylens G, Elaut E.

Horm Behav. 2019 Mar 2;110:29-39. doi: 10.1016/j.yhbeh.2019.02.016. [Epub ahead of print]

PMID:
30822410
6.

Assessment of Gender-Affirming Hormone Therapy Requirements.

Fernandez JD, Kendjorsky K, Narla A, Villasante-Tezanos AG, Tannock LR.

LGBT Health. 2019 Feb 27. doi: 10.1089/lgbt.2018.0116. [Epub ahead of print]

PMID:
30810452
7.

Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women.

Chaikittisilpa S, Soimongkol K, Jaisamrarn U.

Climacteric. 2019 Feb 27:1-6. doi: 10.1080/13697137.2019.1577378. [Epub ahead of print]

PMID:
30810382
8.

Ultrastructural Study of Clitoral Cavernous Tissue and Clitoral Blood Flow From Type 1 Diabetic Premenopausal Women on Phosphodiesterase-5 Inhibitor.

Caruso S, Cianci A, Cianci S, Monaco C, Fava V, Cavallari V.

J Sex Med. 2019 Mar;16(3):375-382. doi: 10.1016/j.jsxm.2019.01.003. Epub 2019 Feb 14.

PMID:
30773497
9.

Hematology reference intervals for transgender adults on stable hormone therapy.

Greene DN, McPherson GW, Rongitsch J, Imborek KL, Schmidt RL, Humble RM, Nisly N, Dole NJ, Dane SK, Frerichs J, Krasowski MD.

Clin Chim Acta. 2019 May;492:84-90. doi: 10.1016/j.cca.2019.02.011. Epub 2019 Feb 13.

PMID:
30771301
10.

Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS).

Januszewski M, Issat T, Jakimiuk AA, Santor-Zaczynska M, Jakimiuk AJ.

Ginekol Pol. 2019;90(1):7-10. doi: 10.5603/GP.2019.0002.

11.

Climacteric status at the age of 46: impact on metabolic outcomes in population-based study.

Savukoski S, Mäkelä H, Auvinen J, Jokelainen J, Puukka K, Ebeling T, Suvanto E, Niinimäki M.

J Clin Endocrinol Metab. 2019 Feb 8. doi: 10.1210/jc.2018-02025. [Epub ahead of print]

PMID:
30753521
12.

Sex hormone replacement therapy in periodontology-A systematic review.

Chaves JDP, Figueredo TFM, Warnavin SVSC, Pannuti CM, Steffens JP.

Oral Dis. 2019 Feb 10. doi: 10.1111/odi.13059. [Epub ahead of print] Review.

PMID:
30739380
13.

Sex hormones and stroke: Beyond estrogens.

Sohrabji F, Okoreeh A, Panta A.

Horm Behav. 2018 Nov 20. pii: S0018-506X(18)30364-7. doi: 10.1016/j.yhbeh.2018.10.010. [Epub ahead of print] Review.

PMID:
30713101
14.

The Management of Heavy Menstrual Bleeding After Percutaneous Coronary Intervention in a Woman of Reproductive Age.

Gu ZC, Shi FH, Zhu J, Wan F, Shen L, Li H.

Front Pharmacol. 2019 Jan 15;9:1573. doi: 10.3389/fphar.2018.01573. eCollection 2018.

15.

Breast Cancer Development in a Transgender Male Receiving Testosterone Therapy.

Barghouthi N, Turner J, Perini J.

Case Rep Endocrinol. 2018 Dec 31;2018:3652602. doi: 10.1155/2018/3652602. eCollection 2018.

16.

Sexual Function Under Adequate Estrogen Therapy in Women After Oophorectomy Versus Natural Menopause.

Zilio Rech CM, Clapauch R, Bouskela E.

J Womens Health (Larchmt). 2019 Jan 25. doi: 10.1089/jwh.2017.6905. [Epub ahead of print]

PMID:
30681390
17.

Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.

Ostadmohammadi V, Jamilian M, Bahmani F, Asemi Z.

J Ovarian Res. 2019 Jan 21;12(1):5. doi: 10.1186/s13048-019-0480-x.

18.
19.

A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.

Javed Z, Papageorgiou M, Deshmukh H, Kilpatrick ES, Mann V, Corless L, Abouda G, Rigby AS, Atkin SL, Sathyapalan T.

Nutrients. 2019 Jan 17;11(1). pii: E188. doi: 10.3390/nu11010188.

20.

Impact of gender and gender disparities in patients with kidney disease.

Brar A, Markell M.

Curr Opin Nephrol Hypertens. 2019 Mar;28(2):178-182. doi: 10.1097/MNH.0000000000000482.

PMID:
30652978

Supplemental Content

Loading ...
Support Center